Waldenström's macroglobulinemia 

Waldenström’s macroglobulinaemia (also known as lymphoplasmacytic lymphoma) is a rare form of bone marrow cancer, which is associated in most cases with the presence of an excessive amount of protein in the blood. Due to the rarity of the condition, a specialist clinic has been set up to address the specific needs of this patient group.

Paraprotein-associated or Paraproteinaemic neuropathy is a condition affecting the peripheral nerves, associated with the presence of a protein in the blood known as a paraprotein. The Joint Neuropathy Clinic, held every two months at the National Hospital for Neurology and Neurosurgery, together with Dr Michael Lunn, Consultant Neurologist with a specialist interest in inflammatory neuropathies, provides multi-specialist input for patients with this condition.

Conditions treated

  • Waldenström’s macroglobulinaemia
  • Cold Haemagglutinin Disease (CHAD)
  • Bing-Neel Syndrome (central nervous system involvement by WM)
  • Paraprotein-associated neuropathies including anti-MAG neuropathy
  • Cryoglobulinaemia


Dr Shirley D’Sa, Consultant Haematologist

Dr Shirley D'Sa

Dr D’Sa specialises in the treatment of Waldenströms macroglobulinaemia, paraproteinaemic neuropathies, Bing-Neel syndrome, POEMS syndrome and Myeloma and Solitary Bone Plasmacytoma. She is also an honorary Senior Lecturer at the UCL Cancer Institute.

“UCLH is an enabling and forward-facing institution with excellent academic links. It is a pleasure to be able to work in close knit clinical teams with medical, nursing colleagues and support staff who collectively strive to work for the patients. I have had the good fortune to meet and look after patients with relatively rare conditions, many of whom are motivated to work together to improve the outlook for Waldenströms patients through the work of a self-styled doctor-patient charity, WMUK (www.wmuk.org.uk)“

Full consultant profile

 Clinical Nurse Specialists (CNS)

Catherine Yeomans, Clinical Nurse Specialist

Catherine Yeomans

Catherine specialises in Myeloma, Waldenströms Macroglobunaemia and other plasma cell disorders. She has specialised in haemato-oncology for eight years and completed a BSc in Haemato-oncology care.

“The most rewarding part of my role is meeting many different people at various stages of their diagnosis when they first come for treatment. With our pioneering Cancer Centre, we are able to provide patients with cutting edge treatments in a therapeutic, and holistic environment. This enables interaction with patients to be delivered in a way that is conducive to flexibility, providing an overall better experience for the patient and family”